Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma

Jun Wang(Rutgers Sexual and Reproductive Health and Rights), Qinglong Guo(Nanjing Tech University), Qing Zhao(China Pharmaceutical University), Jingjing Rong(China Pharmaceutical University), Na Lu(Shandong Maternal and Child Health Hospital), Qidong You(China Pharmaceutical University), Qi Qi(Bengbu Medical College), Wei Liu(Second People’s Hospital of Yibin), Yong Yang(Guilin Medical University), Fei-Fei Nei(China Pharmaceutical University)
Toxicology
December 3, 2008
10.1016/j.tox.2008.11.014
Cited by 39

Related Papers

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Correction: Corrigendum: The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies
|Nature Communications|2017|645
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
|Journal of Neuroinflammation|2020|609
Quercetin alleviates acute kidney injury by inhibiting ferroptosis
|Journal of Advanced Research|2020|601
Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
|Journal of Medicinal Chemistry|2014|587